How Health Technology sector is valued, where its profits sit and how widely its strength is spread across 154 listed companies.
154 companies · ₹30.20L cr combined market cap · prices to 9 Nov
Twelve months of earnings momentum against price strength relative to the market.
Earnings is the sector’s median fundamental score minus 50; price is the sector index’s 6-month return minus the market’s. Each dot is a month-end.
343.3 index level · +23.8% over 12 months
343.3 index level · +77.0% over 3 years
343.3 index level · +246.6% since Jan '19
ApnaFunda's market-cap-weighted index of today's Health Technology companies.
Both mattered.
Earnings helped, the multiple did not.
Mostly earnings.
"pts" are percentage points of the return. The parts add up to the total shown for each period. Because market value = P/E × net profit, higher profit and a higher P/E both push it up.
Example: if the sector rose 30%, profit growth accounts for +45 pts and a lower P/E for -15 pts, then 45 - 15 = 30. The +45 is not the profit growth rate itself: it is the part of the move that profit growth explains.
Only companies with positive profit at both ends are included, so figures can differ slightly from the headline.
Profit is trailing twelve months, with a 60 day reporting lag.
Usual range 20.6x to 38.6x since Jan 2019.
Usual range 2.5x to 4.5x since Jan 2019.
The chart loads when you open this tab.
Usual range 1.9x to 4.0x since Jan 2019.
The chart loads when you open this tab.
Percentiles describe where today's median sits in the sector's own history.
Each month, the line is the median multiple of the sector's companies with a positive multiple, and the band covers the middle half of them (25th to 75th percentile). At least 5 companies are needed for a month to be shown.
The aggregate divides the sector's total market cap by its total net profit (or book value), so it is weighted towards the largest companies. Constituents are today's listed companies, so companies that have since delisted are missing (survivorship bias).
Each band is a company's share of the sum of positive net profit (TTM, reported with a 60-day lag), sampled quarterly. The seven largest earners today keep their own band throughout; the rest are grouped as Others.
Company by company, the typical share price implies 11.0 pts a year more growth than the company delivered. Delivered is the typical company's growth over the last 10 years. Implied vs delivered →
Of the +56.4 pts growth in the market's combined reported earnings, 12 months to Nov '26. See Market Pulse
Higher on the chart is a better rank.
Sectors are ranked each month on price, earnings and FII/DII buying together.
The share of Health Technology companies doing well on each measure.
Above 50% means most companies are.
Each chart runs from 0% (bottom) to 100% (top), monthly.
Hover or tap for a month's value.
Companies below ₹500 cr market cap are left out. A ROCE or ROE change within ±1 pt, or an FII holding change within ±0.25 pt, counts as unchanged. Shareholding is reported quarterly, so the FII chart moves in steps and starts later, when shareholding history begins.
Based on 130 companies' 12-month price returns, weighted by market cap 12 months ago.
A year with an index move under 5% is called flat. Narrow means the top 3 contributors made up at least 60% of the move, or fewer than 35% of companies beat the index in a rising year. Broad means most companies moved with the index.
The highest- and lowest-ranked of 113 Health Technology companies above ₹500 cr on each lens, as of 9 Nov 2026.
Rankings combine price (3-month change), earnings (12-month change in EPS growth, ROCE and operating margin) and FII/DII buying (12-month change in holding).
Market-cap-weighted holding of Health Technology companies over the last 8 quarters.
Public and others is what the three groups leave.
See the Sep 2026 sector flows
The sector's market value is split across 153 companies, but unevenly: as evenly as 19 equal-sized companies would split it.
Higher means market value is spread across more companies; lower means a few companies dominate.
This is the effective number of companies: 1 divided by the sum of squared market-cap weights. A sector of 7 equal-sized companies scores 7. One giant among many small companies scores close to 1. Under 5 reads as highly concentrated, 5 to 15 as moderately concentrated, and over 15 as broad.
Each industry's slice of the sector's market value and of its profit.
A profit bar longer than the market-cap bar means the industry earns more than it is valued for.
Select an industry to filter the company list.
Industries with fewer than 3 companies are grouped as "Other industries". Both bars share one scale.
12m return is the market-cap-weighted 12-month price return of the industry's constituents, with weights from 12 months ago. Mcap and profit shares are each industry's part of the sector total.
| Company | Industry | Mcap | Weight | 12m return | P/E | P/B | ROCE | OPM | D/E | FII Δ 1y | Promoter | 52w range |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES | Pharmaceuticals: Major | ₹4.57L cr | 15.1% | +4%Q2 | 37.8xQ3 | 5.5xQ3 | 21.0%Q3 | 29.0%Q4 | 0.1xQ1 | -2.7Q1 | 54.5% | 69% |
| DIVIS LABORATORIES LIMITED | Pharmaceuticals: Major | ₹3.07L cr | 10.2% | +79%Q4 | 105.0xQ4 | 18.3xQ4 | 22.0%Q4 | 41.0%Q4 | 0.0xQ1 | +0.5Q4 | 51.9% | 96% |
| TORRENT PHARMACEUTICALS LTD | Pharmaceuticals: Major | ₹1.82L cr | 6.0% | +28%Q3 | 75.0xQ4 | 21.7xQ4 | 15.0%Q3 | 34.0%Q4 | 1.8xQ4 | -0.7Q2 | 68.3% | 73% |
| LAURUS LABS LIMITED | Pharmaceuticals: Major | ₹1.33L cr | 4.4% | +138%Q4 | 121.3xQ4 | 25.0xQ4 | 18.0%Q3 | 32.0%Q4 | 0.5xQ4 | +2.3Q4 | 27.5% | 98% |
| ZYDUS LIFESCIENCES LIMITED | Pharmaceuticals: Major | ₹1.21L cr | 4.0% | +29%Q3 | 27.1xQ2 | 4.5xQ3 | 21.0%Q3 | 24.0%Q3 | 0.5xQ4 | -0.2Q2 | 75.0% | 88% |
| DR REDDYS LABORATORIES LTD | Pharmaceuticals: Major | ₹1.16L cr | 3.8% | +10%Q3 | 35.9xQ2 | 3.0xQ2 | 13.0%Q2 | 11.0%Q2 | 0.2xQ2 | -4.7Q1 | 26.6% | 91% |
| CIPLA LIMITED | Pharmaceuticals: Other | ₹1.13L cr | 3.8% | -8%Q2 | 33.6xQ2 | 3.3xQ2 | 15.0%Q3 | 17.0%Q3 | 0.0xQ1 | -5.0Q1 | 29.2% | 64% |
| MANKIND PHARMA LIMITED | Pharmaceuticals: Major | ₹1.10L cr | 3.6% | +19%Q3 | 53.9xQ3 | 6.8xQ4 | 14.0%Q2 | 26.0%Q4 | 0.4xQ3 | -3.6Q1 | 72.6% | 95% |
| AUROBINDO PHARMA LTD | Pharmaceuticals: Other | ₹1.07L cr | 3.5% | +51%Q4 | 28.9xQ2 | 2.8xQ2 | 13.0%Q2 | 21.0%Q3 | 0.2xQ2 | +2.0Q4 | 51.9% | 100% |
| LUPIN LIMITED | Pharmaceuticals: Other | ₹92602 cr | 3.1% | -3%Q2 | 16.7xQ1 | 4.1xQ3 | 30.0%Q4 | 30.0%Q4 | 0.3xQ3 | +1.2Q4 | 46.9% | 21% |
| GLENMARK PHARMACEUTICALS LTD | Pharmaceuticals: Major | ₹75375 cr | 2.5% | +37%Q3 | 41.9xQ3 | 7.2xQ4 | 40.0%Q4 | 20.0%Q3 | 0.1xQ2 | +0.3Q4 | 46.6% | 95% |
| ALKEM LABORATORIES LIMITED | Pharmaceuticals: Major | ₹64541 cr | 2.1% | -5%Q2 | 29.9xQ2 | 4.7xQ3 | 21.0%Q3 | 20.0%Q3 | 0.1xQ2 | +1.3Q4 | 49.7% | 52% |
| BIOCON LIMITED | Pharmaceuticals: Major | ₹60020 cr | 2.0% | -7%Q2 | 109.7xQ4 | 1.8xQ1 | 4.0%Q1 | 20.0%Q3 | 0.5xQ3 | +2.1Q4 | 44.7% | 39% |
| ABBOTT INDIA LIMITED | Pharmaceuticals: Major | ₹56695 cr | 1.9% | -9%Q2 | 35.1xQ2 | 11.9xQ4 | 45.0%Q4 | 29.0%Q4 | 0.0xQ1 | +0.2Q3 | 75.0% | 39% |
| GLAND PHARMA LIMITED | Pharmaceuticals: Major | ₹54492 cr | 1.8% | +88%Q4 | 48.2xQ3 | 5.3xQ3 | 15.0%Q3 | 27.0%Q4 | 0.0xQ1 | +1.4Q4 | 51.8% | 96% |
| ANTHEM BIOSCIENCES LIMITED | Biotechnology | ₹53963 cr | 1.8% | +51%Q4 | 93.5xQ4 | 17.7xQ4 | 30.0%Q4 | 36.0%Q4 | 0.0xQ1 | — | 71.4% | 92% |
| IPCA LABORATORIES LTD | Pharmaceuticals: Major | ₹49713 cr | 1.6% | +35%Q3 | 38.0xQ3 | 6.2xQ3 | 17.0%Q3 | 24.0%Q3 | 0.1xQ2 | +0.1Q3 | 44.7% | 90% |
| GLAXOSMITHKLINE PHARMACEUTICAL | Pharmaceuticals: Major | ₹45915 cr | 1.5% | +8%Q3 | 43.0xQ3 | 20.3xQ4 | 61.0%Q4 | 31.0%Q4 | 0.0xQ1 | -0.1Q2 | 75.0% | 60% |
| EMCURE PHARMACEUTICALS LIMITED | Pharmaceuticals: Major | ₹42039 cr | 1.4% | +57%Q4 | 41.5xQ3 | 8.5xQ4 | 24.0%Q4 | 21.0%Q3 | 0.3xQ3 | +2.0Q4 | 77.8% | 81% |
| AJANTA PHARMA LTD | Pharmaceuticals: Major | ₹41784 cr | 1.4% | +31%Q3 | 36.8xQ2 | 9.2xQ4 | 35.0%Q4 | 26.0%Q4 | 0.1xQ2 | -1.2Q1 | 63.5% | 67% |
| SAI LIFE SCIENCES LIMITED | Pharmaceuticals: Major | ₹39015 cr | 1.3% | +108%Q4 | 107.3xQ4 | 15.7xQ4 | 20.0%Q3 | 27.0%Q4 | 0.1xQ2 | +5.1Q4 | 34.5% | 95% |
| WOCKHARDT LTD | Pharmaceuticals: Major | ₹33016 cr | 1.1% | +64%Q4 | 80.7xQ4 | 6.7xQ4 | 8.0%Q2 | 21.0%Q3 | 0.5xQ3 | -0.1Q2 | 49.1% | 71% |
| PIRAMAL PHARMA LIMITED | Pharmaceuticals: Major | ₹32788 cr | 1.1% | +32%Q3 | — | 4.0xQ3 | 3.0%Q1 | 8.6%Q1 | 0.7xQ4 | -18.4Q1 | 34.8% | 97% |
| RUBICON RESEARCH LIMITED | Pharmaceuticals: Generic | ₹29338 cr | 1.0% | +170%Q4 | 100.2xQ4 | 22.8xQ4 | 28.0%Q4 | 24.0%Q3 | 0.2xQ3 | — | 59.8% | 90% |
| INVENTURUS KNOWLEDGE SOLU LTD | Medical Specialties | ₹28343 cr | 0.9% | -2%Q2 | 37.1xQ3 | 10.1xQ4 | 32.0%Q4 | 32.0%Q4 | 0.3xQ3 | +1.5Q4 | 63.7% | 55% |
| NEULAND LABORATORIES LIMITED | Pharmaceuticals: Major | ₹26073 cr | 0.9% | +18%Q3 | 52.4xQ3 | 13.9xQ4 | 26.0%Q4 | 35.0%Q4 | 0.2xQ2 | -0.6Q2 | 32.6% | 69% |
| GRANULES INDIA LIMITED | Pharmaceuticals: Other | ₹21794 cr | 0.7% | +44%Q4 | 29.6xQ2 | 4.3xQ3 | 16.0%Q3 | 23.0%Q3 | 0.3xQ3 | +4.3Q4 | 38.0% | 68% |
| ALEMBIC PHARMACEUTICALS LIMITE | Pharmaceuticals: Major | ₹19993 cr | 0.7% | +12%Q3 | 28.8xQ2 | 3.5xQ2 | 13.0%Q2 | 15.0%Q2 | 0.3xQ3 | +0.2Q3 | 69.9% | 91% |
| CAPLIN POINT LABORATORIES LTD | Pharmaceuticals: Major | ₹19018 cr | 0.6% | +31%Q3 | 28.6xQ2 | 5.6xQ3 | 24.0%Q4 | 35.0%Q4 | 0.1xQ2 | -0.4Q2 | 70.6% | 67% |
| ONESOURCE SPECIALTY PHARMA LTD | Pharmaceuticals: Major | ₹18555 cr | 0.6% | +6%Q2 | — | 3.2xQ2 | 1.0%Q1 | 27.0%Q4 | 0.2xQ2 | +0.5Q4 | 30.5% | 65% |
| SHILPA MEDICARE LIMITED | Pharmaceuticals: Major | ₹18257 cr | 0.6% | +173%Q4 | 61.4xQ4 | 7.0xQ4 | 11.0%Q2 | 29.0%Q4 | 0.3xQ3 | +0.2Q3 | 40.1% | 81% |
| ALIVUS LIFE SCIENCES LIMITED | Pharmaceuticals: Major | ₹18105 cr | 0.6% | +64%Q4 | 45.2xQ3 | — | — | — | — | -0.9Q1 | 74.9% | 87% |
| PFIZER LTD | Pharmaceuticals: Major | ₹17923 cr | 0.6% | -21%Q1 | 39.0xQ3 | 19.9xQ4 | 27.0%Q4 | — | 0.0xQ1 | -0.8Q1 | 63.9% | 19% |
| ERIS LIFESCIENCES LIMITED | Pharmaceuticals: Major | ₹17510 cr | 0.6% | -21%Q1 | 27.0xQ2 | 4.5xQ3 | 14.0%Q2 | 34.0%Q4 | 0.6xQ4 | -2.6Q1 | 54.1% | 29% |
| COHANCE LIFESCIENCES LIMITED | Pharmaceuticals: Major | ₹16986 cr | 0.6% | -21%Q1 | 159.6xQ4 | 4.3xQ3 | 6.0%Q1 | 0.3%Q1 | 0.1xQ2 | -0.7Q2 | 57.5% | 37% |
| POLY MEDICURE LTD | Medical Specialties | ₹16357 cr | 0.5% | -17%Q1 | 51.9xQ3 | 5.3xQ3 | 12.0%Q2 | 24.0%Q3 | 0.1xQ2 | -5.8Q1 | 62.4% | 47% |
| ASTRAZENECA PHARMA INDIA LTD | Pharmaceuticals: Major | ₹16287 cr | 0.5% | -28%Q1 | 96.0xQ4 | 18.7xQ4 | 29.0%Q4 | 7.0%Q1 | 0.1xQ2 | -0.3Q2 | 75.0% | 21% |
| NATCO PHARMA LIMITED | Pharmaceuticals: Major | ₹15787 cr | 0.5% | -8%Q2 | 13.8xQ1 | 1.7xQ1 | 17.0%Q3 | 25.0%Q4 | 0.1xQ2 | +1.5Q4 | 49.4% | 7% |
| CORONA REMEDIES LIMITED | Pharmaceuticals: Other | ₹15528 cr | 0.5% | — | 78.0xQ4 | 20.8xQ4 | 33.0%Q4 | 22.0%Q3 | 0.2xQ2 | — | 69.0% | 87% |
| MOLBIO DIAGNOSTICS LTD | Medical Specialties | ₹15397 cr | 0.5% | — | 90.5xQ4 | 13.2xQ4 | 18.0%Q3 | — | 0.4xQ3 | — | — | — |
| JUBILANT PHARMOVA LIMITED | Pharmaceuticals: Major | ₹15385 cr | 0.5% | -11%Q1 | 43.7xQ3 | 2.2xQ2 | 9.0%Q2 | 11.0%Q2 | 0.5xQ4 | -1.5Q1 | 47.7% | 45% |
| INDEGENE LTD | Medical Specialties | ₹14806 cr | 0.5% | +16%Q3 | 36.9xQ3 | 4.7xQ3 | 19.0%Q3 | 16.0%Q2 | 0.1xQ1 | -0.1Q2 | — | 90% |
| MARKSANS PHARMA LIMITED | Pharmaceuticals: Major | ₹14001 cr | 0.5% | +64%Q4 | 27.1xQ2 | 4.6xQ3 | 19.0%Q3 | 25.0%Q4 | 0.1xQ2 | -2.4Q1 | 43.9% | 79% |
| ANUPAM RASAYAN INDIA LIMITED | Pharmaceuticals: Major | ₹13637 cr | 0.5% | -2%Q2 | 78.1xQ4 | 4.1xQ3 | 7.0%Q2 | 25.0%Q4 | 0.6xQ4 | +2.8Q4 | 59.1% | 40% |
| AKUMS DRUGS AND PHARMA LTD | Pharmaceuticals: Major | ₹12050 cr | 0.4% | +80%Q4 | 41.3xQ3 | 3.6xQ2 | 15.0%Q3 | 15.0%Q2 | 0.1xQ1 | -2.3Q1 | 75.3% | 83% |
| BLUE JET HEALTHCARE LIMITED | Pharmaceuticals: Major | ₹10279 cr | 0.3% | -6%Q2 | 68.2xQ4 | 30.2xQ4 | 57.0%Q4 | — | 0.2xQ2 | -1.6Q1 | 79.8% | 60% |
| SYMBIOTEC PHARMALAB LTD | Pharmaceuticals: Generic | ₹9992 cr | 0.3% | — | 88.8xQ4 | 8.7xQ4 | 13.0%Q2 | — | 0.3xQ3 | — | — | — |
| PROCTER AND GAMBLE HEALTH LTD | Pharmaceuticals: Major | ₹9462 cr | 0.3% | +3%Q2 | 26.5xQ2 | 18.0xQ4 | 84.0%Q4 | 27.0%Q4 | 0.0xQ1 | -0.7Q2 | 51.8% | 44% |
| STRIDES PHARMA SCIENCE LTD | Pharmaceuticals: Major | ₹9235 cr | 0.3% | +14%Q3 | 15.1xQ1 | 3.0xQ2 | 18.0%Q3 | 18.0%Q3 | 0.6xQ4 | +0.4Q4 | 27.9% | 47% |
| AARTI PHARMALABS LIMITED | Pharmaceuticals: Major | ₹8353 cr | 0.3% | +32%Q3 | 39.2xQ3 | 3.9xQ3 | 11.0%Q2 | 25.0%Q4 | 0.3xQ3 | +0.8Q4 | 42.9% | 81% |
| SUVEN LIFE SCIENCES LIMITED | Pharmaceuticals: Major | ₹7906 cr | 0.3% | +63%Q4 | — | 13.4xQ4 | -80.0%Q1 | -3711.0%Q1 | 0.0xQ1 | -0.0Q3 | 70.1% | 56% |
| SANOFI INDIA LTD | Pharmaceuticals: Major | ₹7668 cr | 0.3% | -22%Q1 | 18.5xQ1 | 8.9xQ4 | 49.0%Q4 | 23.0%Q3 | 0.0xQ1 | +0.1Q3 | 60.4% | 32% |
| BLISS GVS PHARMA LIMITED | Pharmaceuticals: Generic | ₹6958 cr | 0.2% | +294%Q4 | 50.9xQ3 | 5.8xQ3 | 17.0%Q3 | 27.0%Q4 | 0.0xQ1 | -4.6Q1 | 35.0% | 86% |
| SUN PHARMA ADVANCED RESEARCH C | Pharmaceuticals: Major | ₹6859 cr | 0.2% | +57%Q4 | 4.3xQ1 | 5.1xQ3 | 164.0%Q4 | -85.0%Q1 | 0.4xQ3 | +2.4Q4 | 65.7% | 57% |
| FDC LIMITED | Pharmaceuticals: Major | ₹6418 cr | 0.2% | -5%Q2 | 21.9xQ2 | 2.6xQ2 | 15.0%Q3 | 21.0%Q3 | 0.0xQ1 | -1.0Q1 | 69.7% | 53% |
| CONCORD BIOTECH LIMITED | Pharmaceuticals: Other | ₹6241 cr | 0.2% | -16%Q1 | 22.7xQ2 | 3.1xQ2 | 17.0%Q3 | 32.0%Q4 | 0.0xQ1 | -1.6Q1 | 44.1% | 33% |
| INNOVA CAPTAB LIMITED | Pharmaceuticals: Major | ₹6118 cr | 0.2% | +49%Q4 | 39.7xQ3 | 5.6xQ3 | 15.0%Q3 | 16.0%Q2 | 0.3xQ3 | +0.1Q3 | 50.9% | 61% |
| MOREPEN LABORATORIES LIMITED | Pharmaceuticals: Generic | ₹5466 cr | 0.2% | +128%Q4 | 38.6xQ3 | 4.4xQ3 | 8.0%Q2 | 14.0%Q2 | 0.2xQ2 | -0.3Q2 | 35.7% | 56% |
| SENORES PHARMACEUTICALS LTD | Pharmaceuticals: Major | ₹5411 cr | 0.2% | +43%Q3 | 42.8xQ3 | 5.8xQ3 | 15.0%Q3 | 30.0%Q4 | 0.4xQ3 | +3.0Q4 | 45.8% | 53% |
| ORCHID PHARMA LIMITED | Pharmaceuticals: Major | ₹5297 cr | 0.2% | +6%Q2 | 420.9xQ4 | 3.5xQ2 | 2.0%Q1 | 4.6%Q1 | 0.2xQ2 | -0.6Q2 | 69.8% | 61% |
| SUPRIYA LIFESCIENCE LIMITED | Pharmaceuticals: Major | ₹5082 cr | 0.2% | -16%Q1 | 25.6xQ2 | 4.2xQ3 | 25.0%Q4 | 25.0%Q4 | 0.0xQ1 | -0.6Q2 | 68.3% | 16% |
| SAHAJANAND MEDICAL TECH L | Medical Specialties | ₹5007 cr | 0.2% | — | 76.5xQ4 | 7.2xQ4 | 11.0%Q2 | — | 0.4xQ3 | — | — | — |
| GUJARAT THEMIS BIOSYN LTD | Pharmaceuticals: Major | ₹4944 cr | 0.2% | -7%Q2 | 88.7xQ4 | — | — | — | — | -0.8Q1 | 70.9% | 63% |
| SMS PHARMACEUTICALS LTD | Pharmaceuticals: Major | ₹4810 cr | 0.2% | +61%Q4 | 47.0xQ3 | 6.1xQ3 | 13.0%Q2 | 20.0%Q3 | 0.5xQ4 | +0.6Q4 | 68.1% | 92% |
| GUFIC BIOSCIENCES LIMITED | Pharmaceuticals: Major | ₹4752 cr | 0.2% | +33%Q3 | 64.8xQ4 | 7.2xQ4 | 12.0%Q2 | 18.0%Q3 | 0.6xQ4 | +0.1Q3 | 72.5% | 97% |
| AARTI DRUGS LIMITED | Pharmaceuticals: Major | ₹4563 cr | 0.2% | +18%Q3 | 23.9xQ2 | 3.0xQ2 | 12.0%Q2 | 14.0%Q2 | 0.4xQ3 | -0.7Q2 | 54.4% | 84% |
| ZOTA HEALTH CARE LTD | Pharmaceuticals: Major | ₹4410 cr | 0.1% | -19%Q1 | — | 6.3xQ3 | -8.0%Q1 | -7.0%Q1 | 0.4xQ3 | +4.1Q4 | 49.4% | 35% |
| RPG LIFE SCIENCES LIMITED | Pharmaceuticals: Major | ₹4293 cr | 0.1% | +14%Q3 | 35.9xQ2 | 7.1xQ4 | 26.0%Q4 | 22.0%Q3 | 0.0xQ1 | -0.4Q2 | 73.0% | 62% |
| KWALITY PHARMACEUTICALS LTD | Pharmaceuticals: Major | ₹4002 cr | 0.1% | — | 49.4xQ3 | 12.1xQ4 | 24.0%Q4 | 25.0%Q4 | 0.4xQ3 | — | 54.9% | — |
| SHUKRA PHARMACEUTICALS LIMITED | Pharmaceuticals: Major | ₹3629 cr | 0.1% | — | 108.0xQ4 | 40.3xQ4 | 37.0%Q4 | 81.0%Q4 | 0.1xQ1 | — | 51.0% | — |
| UNICHEM LABORATORIES LTD | Pharmaceuticals: Major | ₹3583 cr | 0.1% | +9%Q3 | 11.8xQ1 | 1.3xQ1 | 4.0%Q1 | 11.0%Q2 | 0.2xQ2 | -0.1Q2 | 70.2% | 56% |
| SOLARA ACTIVE PHARMA SCIEN LTD | Pharmaceuticals: Major | ₹3143 cr | 0.1% | +26%Q3 | — | 2.5xQ2 | 5.0%Q1 | 16.0%Q2 | 0.6xQ4 | -2.7Q1 | 41.9% | 64% |
| IND-SWIFT LABORATORIES LIMITED | Pharmaceuticals: Major | ₹3037 cr | 0.1% | +258%Q4 | 51.9xQ3 | 2.2xQ2 | 5.0%Q1 | 17.0%Q3 | 0.0xQ1 | +6.4Q4 | 42.9% | 77% |
| HIKAL LIMITED | Pharmaceuticals: Major | ₹2774 cr | 0.1% | +1%Q2 | — | 2.3xQ2 | 4.0%Q1 | 9.2%Q2 | 0.6xQ4 | -4.4Q1 | 68.8% | 69% |
| ALEMBIC LTD | Pharmaceuticals: Major | ₹2738 cr | 0.1% | +9%Q3 | 8.5xQ1 | 1.1xQ1 | 6.0%Q1 | 32.0%Q4 | 0.0xQ1 | -0.3Q2 | 70.9% | 77% |
| DISHMAN CARBOGEN AMCIS LIMITED | Pharmaceuticals: Major | ₹2621 cr | 0.1% | -30%Q1 | 162.2xQ4 | 0.4xQ1 | 3.0%Q1 | 9.0%Q1 | 0.5xQ4 | -3.1Q1 | 59.3% | 22% |
| FREDUN PHARMACEUTICALS LIMITED | Pharmaceuticals: Major | ₹2602 cr | 0.1% | — | 54.9xQ4 | 9.4xQ4 | 21.0%Q3 | 14.0%Q2 | 0.8xQ4 | — | 44.6% | — |
| SAKAR HEALTHCARE LIMITED | Pharmaceuticals: Major | ₹2288 cr | 0.1% | +174%Q4 | 63.4xQ4 | 7.1xQ4 | 12.0%Q2 | 29.0%Q4 | 0.2xQ2 | -1.3Q1 | 52.5% | 77% |
| SAI PARENTERALS LIMITED | Pharmaceuticals: Generic | ₹2236 cr | 0.1% | — | 145.0xQ4 | 4.5xQ3 | 5.0%Q1 | 13.2%Q2 | 1.0xQ4 | — | 51.2% | — |
| PANACEA BIOTEC LTD | Pharmaceuticals: Major | ₹2211 cr | 0.1% | -2%Q2 | — | 2.6xQ2 | -2.0%Q1 | 2.8%Q1 | 0.0xQ1 | +1.5Q4 | 72.5% | 19% |
| BETA DRUGS LIMITED | Pharmaceuticals: Major | ₹2093 cr | 0.1% | +13%Q3 | 43.1xQ3 | 8.5xQ4 | 19.0%Q3 | 22.0%Q3 | 0.6xQ4 | +0.1Q3 | 59.1% | 49% |
| INDOCO REMEDIES LIMITED | Pharmaceuticals: Major | ₹2028 cr | 0.1% | -14%Q1 | 359.6xQ4 | 2.2xQ2 | 1.0%Q1 | 9.0%Q1 | 1.2xQ4 | +0.1Q3 | 58.9% | 45% |
| WINDLAS BIOTECH LIMITED | Pharmaceuticals: Major | ₹2011 cr | 0.1% | +24%Q3 | 30.9xQ2 | 3.5xQ2 | 16.0%Q3 | 11.0%Q2 | 0.1xQ2 | +0.6Q4 | 63.3% | 57% |
| HESTER BIOSCIENCES LTD | Pharmaceuticals: Major | ₹1964 cr | 0.1% | +40%Q3 | 14.4xQ1 | 5.4xQ3 | 15.0%Q3 | 29.0%Q4 | 0.5xQ4 | -0.2Q2 | 53.7% | 74% |
| ANONDITA MEDICARE LIMITED | Medical Specialties | ₹1910 cr | 0.1% | +56%Q4 | 56.9xQ4 | 14.8xQ4 | 44.0%Q4 | — | 0.3xQ3 | — | 62.4% | 69% |
| SYNCOM FORMULATIONS (INDIA) LT | Pharmaceuticals: Major | ₹1894 cr | 0.1% | +29%Q3 | 22.1xQ2 | 4.6xQ3 | 25.0%Q4 | 21.0%Q3 | 0.0xQ1 | -0.1Q2 | 50.6% | 57% |
| NGL FINE CHEM LIMITED | Pharmaceuticals: Major | ₹1814 cr | 0.1% | +119%Q4 | 31.7xQ2 | 5.5xQ3 | 19.0%Q3 | 17.0%Q3 | 0.4xQ3 | +0.1Q3 | 72.5% | 71% |
| VIRTUOSO OPTOELECTRONICS LTD | Medical Specialties | ₹1685 cr | 0.1% | — | 84.4xQ4 | 4.1xQ3 | 10.0%Q2 | 9.1%Q2 | 0.8xQ4 | — | 49.7% | — |
| AMRUTANJAN HEALTH CARE LIMITED | Pharmaceuticals: Other | ₹1502 cr | 0.1% | -24%Q1 | 73.7xQ4 | 13.8xQ4 | 31.0%Q4 | — | 0.0xQ1 | +0.0Q3 | 46.5% | 16% |
| ACCENT MICROCELL LIMITED | Pharmaceuticals: Major | ₹1446 cr | 0.0% | +84%Q4 | 33.0xQ2 | 5.2xQ3 | 25.0%Q4 | — | 0.0xQ1 | +0.9Q4 | 53.0% | 71% |
| JAGSONPAL PHARMACEUTICALS LIMI | Pharmaceuticals: Generic | ₹1436 cr | 0.0% | +1%Q2 | — | — | — | — | — | +0.1Q3 | 69.1% | 57% |
| ANLON HEALTHCARE LIMITED | Pharmaceuticals: Generic | ₹1431 cr | 0.0% | +60%Q4 | 44.1xQ3 | 6.2xQ3 | 21.0%Q3 | 18.0%Q3 | 0.2xQ2 | — | 52.7% | 62% |
| TTK HEALTHCARE LTD | Pharmaceuticals: Major | ₹1311 cr | 0.0% | -17%Q1 | 17.7xQ1 | 1.2xQ1 | 8.0%Q2 | 6.0%Q1 | 0.0xQ1 | -0.0Q3 | 74.6% | 38% |
| FERMENTA BIOTECH LIMITED | Biotechnology | ₹1266 cr | 0.0% | — | 21.2xQ1 | 3.1xQ2 | 21.0%Q3 | 14.8%Q2 | 0.3xQ3 | — | 64.1% | — |
| KOPRAN LTD | Pharmaceuticals: Major | ₹1255 cr | 0.0% | +93%Q4 | 50.1xQ3 | 2.4xQ2 | 7.0%Q2 | 10.3%Q2 | 0.3xQ3 | -0.3Q2 | 44.4% | 81% |
| BHARAT PARENTERALS LIMITED | Pharmaceuticals: Major | ₹1241 cr | 0.0% | — | — | 3.9xQ3 | -2.0%Q1 | 9.0%Q1 | 0.5xQ3 | — | 67.2% | — |
| MIC ELECTRONICS LIMITED | Medical Specialties | ₹1188 cr | 0.0% | -11%Q2 | — | 5.5xQ3 | 9.0%Q2 | 9.7%Q2 | 0.2xQ2 | +2.5Q4 | 51.6% | 36% |
| LAXMI DENTAL LIMITED | Medical Specialties | ₹1123 cr | 0.0% | -26%Q1 | 36.5xQ2 | 4.6xQ3 | 15.0%Q3 | 19.0%Q3 | 0.1xQ1 | -3.5Q1 | 41.8% | 26% |
| BAFNA PHARMACEUTICALS LIMITED | Pharmaceuticals: Generic | ₹1099 cr | 0.0% | +213%Q4 | — | 21.6xQ4 | -3.0%Q1 | — | 0.1xQ2 | 0.0Q3 | 75.0% | 98% |
| BAJAJ HEALTHCARE LIMITED | Pharmaceuticals: Major | ₹1062 cr | 0.0% | -27%Q1 | 54.7xQ4 | 2.0xQ1 | 11.0%Q2 | 17.0%Q3 | 0.5xQ4 | +1.1Q4 | 58.6% | 21% |
| LINCOLN PHARMACEUTICALS LTD | Pharmaceuticals: Major | ₹1044 cr | 0.0% | +2%Q2 | 10.8xQ1 | 1.4xQ1 | 16.0%Q3 | 15.0%Q2 | 0.0xQ1 | -0.5Q2 | 49.8% | 25% |
| SIGACHI INDUSTRIES LIMITED | Pharmaceuticals: Major | ₹1035 cr | 0.0% | -29%Q1 | 40.5xQ3 | 2.0xQ1 | 6.0%Q1 | 13.6%Q2 | 0.3xQ3 | -1.6Q1 | 36.7% | 43% |
| REMUS PHARMACEUTICALS LIMITED | Pharmaceuticals: Generic | ₹967 cr | 0.0% | +19%Q3 | 26.1xQ2 | 2.8xQ2 | 17.0%Q3 | — | 0.1xQ2 | +0.5Q4 | 71.0% | 52% |
| THEMIS MEDICARE LIMITED | Pharmaceuticals: Major | ₹935 cr | 0.0% | -6%Q2 | 23.4xQ2 | 2.4xQ2 | 3.0%Q1 | -60.0%Q1 | 0.3xQ3 | -0.1Q2 | 67.1% | 48% |
| SUDARSHAN PHARMA IND LTD | Pharmaceuticals: Major | ₹851 cr | 0.0% | — | 32.5xQ2 | 5.5xQ3 | 15.0%Q3 | 9.1%Q2 | 1.8xQ4 | — | 58.9% | — |
| ANUH PHARMA LTD | Pharmaceuticals: Major | ₹830 cr | 0.0% | +7%Q3 | 18.8xQ1 | 2.4xQ2 | 15.0%Q3 | 8.0%Q1 | 0.0xQ1 | -0.0Q3 | 71.8% | 49% |
| AMANTA HEALTHCARE LIMITED | Pharmaceuticals: Generic | ₹783 cr | 0.0% | +90%Q4 | 53.6xQ3 | 3.6xQ2 | 12.0%Q2 | 21.1%Q3 | 1.1xQ4 | — | 63.8% | 93% |
| SHREE GANESH REMEDIES LIMITED | Pharmaceuticals: Major | ₹781 cr | 0.0% | — | 50.6xQ3 | 4.8xQ3 | 14.0%Q2 | 23.3%Q3 | 0.2xQ2 | — | 72.8% | — |
| ZIM LABORATORIES LIMITED | Pharmaceuticals: Generic | ₹736 cr | 0.0% | +88%Q4 | 180.1xQ4 | 2.5xQ2 | 5.0%Q1 | 2.6%Q1 | 0.4xQ3 | 0.0Q3 | 30.4% | 77% |
| WANBURY LIMITED | Pharmaceuticals: Major | ₹703 cr | 0.0% | -23%Q1 | 15.3xQ1 | 11.9xQ4 | 37.0%Q4 | 15.0%Q2 | 3.0xQ4 | -0.7Q2 | 43.0% | 20% |
| KILITCH DRUGS (I) LTD | Pharmaceuticals: Major | ₹702 cr | 0.0% | +17%Q3 | 23.4xQ2 | 2.5xQ2 | 13.0%Q2 | 6.5%Q1 | 0.3xQ3 | +0.1Q3 | 63.8% | 55% |
| VALIANT LABORATORIES LIMITED | Pharmaceuticals: Generic | ₹604 cr | 0.0% | +68%Q4 | 37.9xQ3 | 1.9xQ1 | 1.0%Q1 | 25.0%Q4 | 0.1xQ2 | -0.6Q2 | 74.9% | 68% |
| PRAVEG LIMITED | Pharmaceuticals: Major | ₹540 cr | 0.0% | — | — | 1.2xQ1 | 2.0%Q1 | 8.0%Q1 | 0.4xQ3 | — | 46.2% | — |
| ALBERT DAVID LTD | Pharmaceuticals: Major | ₹458 cr | 0.0% | +1%Q2 | 20.3xQ1 | 1.2xQ1 | 1.0%Q1 | 10.0%Q2 | 0.1xQ2 | -0.3Q2 | 62.2% | 63% |
| JENBURKT PHARMACEUTICALS LTD | Pharmaceuticals: Major | ₹421 cr | 0.0% | — | 12.8xQ1 | 2.1xQ1 | 27.0%Q4 | 17.0%Q3 | 0.0xQ1 | — | 46.6% | — |
| MEDICAMEN BIOTECH LTD | Pharmaceuticals: Generic | ₹381 cr | 0.0% | -32%Q1 | 35.0xQ2 | 1.4xQ1 | 6.0%Q1 | 9.0%Q2 | 0.2xQ2 | +0.1Q3 | 40.5% | 28% |
| AAREY DRUGS & PHARMACEUTICALS | Pharmaceuticals: Major | ₹349 cr | 0.0% | +24%Q3 | 74.2xQ4 | 2.3xQ2 | 6.0%Q1 | 3.0%Q1 | 0.3xQ3 | +2.8Q4 | 37.7% | 91% |
| LYKA LABS LTD | Pharmaceuticals: Generic | ₹291 cr | 0.0% | +0%Q2 | — | 3.1xQ2 | -6.0%Q1 | 10.8%Q2 | 0.5xQ4 | +0.0Q3 | 58.5% | 70% |
| YASH OPTICS AND LENS LTD | Medical Specialties | ₹290 cr | 0.0% | -2%Q2 | 32.1xQ2 | 2.9xQ2 | 12.8%Q2 | — | 0.1xQ1 | -0.8Q1 | 73.2% | 44% |
| NURECA LIMITED | Medical Specialties | ₹286 cr | 0.0% | +4%Q2 | 141.8xQ4 | 1.6xQ1 | 2.0%Q1 | 6.1%Q1 | 0.0xQ1 | +0.0Q3 | 68.1% | 57% |
| SAT KARTAR LIFE LIMITED | Pharmaceuticals: Other | ₹245 cr | 0.0% | -13%Q1 | 14.3xQ1 | 3.6xQ2 | 36.0%Q4 | — | 0.0xQ1 | -6.2Q1 | 63.6% | 41% |
| NECTAR LIFESCIENCES LIMITED | Pharmaceuticals: Major | ₹199 cr | 0.0% | -40%Q1 | — | 0.3xQ1 | 0.0%Q1 | -6198.0%Q1 | 0.0xQ1 | -0.3Q2 | 51.8% | 7% |
| BROOKS LABORATORIES LIMITED | Pharmaceuticals: Major | ₹193 cr | 0.0% | -36%Q1 | 14.6xQ1 | 1.6xQ1 | 21.0%Q3 | -5.8%Q1 | 0.1xQ2 | 0.0Q3 | 52.6% | 39% |
| BIO MEDICA LABORATORIES LIMITE | Pharmaceuticals: Generic | ₹186 cr | 0.0% | — | 11.4xQ1 | 7.2xQ4 | 41.0%Q4 | — | 1.5xQ4 | — | 67.7% | — |
| MAKERS LABORATORIES LTD | Pharmaceuticals: Major | ₹159 cr | 0.0% | — | 46.4xQ3 | 2.2xQ2 | 9.0%Q2 | 16.3%Q2 | 0.1xQ2 | — | 61.3% | — |
| MEDICO REMEDIES LTD | Pharmaceuticals: Major | ₹156 cr | 0.0% | -64%Q1 | 11.3xQ1 | 2.1xQ1 | 23.0%Q4 | 4.8%Q1 | 0.3xQ3 | +0.0Q3 | 61.4% | 3% |
| NATURAL CAPSULES LTD | Pharmaceuticals: Generic | ₹153 cr | 0.0% | -21%Q1 | — | 0.9xQ1 | -5.0%Q1 | 2.3%Q1 | 0.9xQ4 | — | 50.9% | 15% |
| VIJAYPD CEUTICAL LTD | Pharmaceuticals: Generic | ₹152 cr | 0.0% | +64%Q4 | 30.3xQ2 | 2.9xQ2 | — | — | 0.7xQ4 | — | 56.4% | 54% |
| SOTAC PHARMACEUTICALS LIMITED | Pharmaceuticals: Major | ₹143 cr | 0.0% | +0%Q2 | 24.9xQ2 | 2.4xQ2 | 12.0%Q2 | — | 0.6xQ4 | +1.7Q4 | 72.8% | 38% |
| QUEST LABORATORIES LIMITED | Pharmaceuticals: Generic | ₹141 cr | 0.0% | -1%Q2 | 9.4xQ1 | 1.5xQ1 | 18.0%Q3 | 12.8%Q2 | 0.1xQ2 | -0.3Q2 | 66.8% | 21% |
| AVIENCE BIOMEDICALS LTD | Medical Specialties | ₹137 cr | 0.0% | — | 11.5xQ1 | 4.4xQ3 | 26.9%Q4 | — | 0.9xQ4 | — | 64.6% | — |
| BAL PHARMA LIMITED | Pharmaceuticals: Generic | ₹133 cr | 0.0% | +10%Q3 | 18.4xQ1 | 1.6xQ1 | 10.0%Q2 | 9.0%Q1 | 1.9xQ4 | 0.0Q3 | 50.9% | 36% |
| KREBS BIOCHEMICALS & INDUSTRIE | Pharmaceuticals: Major | ₹129 cr | 0.0% | -12%Q1 | — | — | -15.0%Q1 | 11.8%Q2 | — | 0.0Q3 | 72.7% | 55% |
| BALAXI PHARMACEUTICALS LIMITED | Pharmaceuticals: Major | ₹125 cr | 0.0% | -38%Q1 | 50.4xQ3 | 0.5xQ1 | 3.0%Q1 | 5.8%Q1 | 0.2xQ3 | -8.9Q1 | 66.0% | 26% |
| PARNAX LAB LIMITED | Pharmaceuticals: Major | ₹124 cr | 0.0% | — | 13.9xQ1 | 1.3xQ1 | 14.0%Q2 | 7.6%Q1 | 0.9xQ4 | — | 72.3% | — |
| ALPA LABORATORIES LIMITED | Pharmaceuticals: Major | ₹119 cr | 0.0% | -28%Q1 | 29.2xQ2 | 0.6xQ1 | 9.0%Q2 | -16.6%Q1 | 0.0xQ1 | -0.0Q3 | 57.2% | 23% |
| AAKAAR MEDICAL TECH LIMITED | Medical Specialties | ₹101 cr | 0.0% | -3%Q2 | 15.1xQ1 | 1.9xQ1 | 18.0%Q3 | — | 0.3xQ3 | -1.9Q1 | 67.0% | 50% |
| VAISHALI PHARMA LIMITED | Pharmaceuticals: Major | ₹95 cr | 0.0% | -20%Q1 | 20.6xQ1 | 1.4xQ1 | — | 6.5%Q1 | 0.3xQ3 | — | 31.6% | 42% |
| VILIN BIO MED LIMITED | Pharmaceuticals: Major | ₹83 cr | 0.0% | +170%Q4 | 43.0xQ3 | 2.9xQ2 | 10.8%Q2 | — | 0.0xQ1 | 0.0Q3 | 56.6% | 85% |
| SUNIL HEALTHCARE LTD | Pharmaceuticals: Major | ₹72 cr | 0.0% | — | 20.1xQ1 | 1.0xQ1 | 6.4%Q2 | 15.4%Q2 | 0.8xQ4 | — | 73.5% | — |
| ZENITH DRUGS LTD | Pharmaceuticals: Major | ₹68 cr | 0.0% | -28%Q1 | 7.1xQ1 | 1.1xQ1 | 27.0%Q4 | — | 0.4xQ3 | -0.1Q2 | 70.0% | 20% |
| MOHINI HEALTH AND HYGIENE LTD | Medical Specialties | ₹51 cr | 0.0% | -32%Q1 | — | 0.6xQ1 | -4.0%Q1 | — | 0.4xQ3 | 0.0Q3 | 64.0% | 7% |
| BIOFIL CHEMICALS & PHARMACEUTI | Pharmaceuticals: Major | ₹50 cr | 0.0% | -18%Q1 | 101.7xQ4 | 2.3xQ2 | 3.0%Q1 | 1.1%Q1 | 0.1xQ2 | 0.0Q3 | 46.8% | 24% |
| MANGALAM DRUGS AND ORGANICS LT | Pharmaceuticals: Major | ₹46 cr | 0.0% | +5%Q2 | — | 0.5xQ1 | -14.0%Q1 | 1.6%Q1 | 1.1xQ4 | -0.4Q2 | 35.6% | 15% |
| ABH HEALTHCARE LIMITED | Pharmaceuticals: Generic | ₹46 cr | 0.0% | — | 5.7xQ1 | 2.7xQ2 | 19.9%Q3 | — | 3.2xQ4 | — | — | — |
| JFL LIFE SCIENCES LIMITED | Pharmaceuticals: Major | ₹43 cr | 0.0% | +13%Q3 | 6.3xQ1 | 0.9xQ1 | 18.0%Q3 | 18.8%Q3 | 0.5xQ4 | — | 67.5% | 71% |
| MEDICAMEN ORGANICS LIMITED | Pharmaceuticals: Generic | ₹39 cr | 0.0% | -5%Q2 | — | 1.3xQ1 | -10.4%Q1 | — | 0.5xQ4 | -0.0Q3 | 54.9% | 31% |
| GKB OPHTHALMICS LIMITED | Medical Specialties | ₹30 cr | 0.0% | — | 9.3xQ1 | 0.6xQ1 | 11.0%Q2 | 8.0%Q1 | 0.2xQ2 | — | 51.1% | — |
| MEDI-CAPS LTD | Pharmaceuticals: Major | ₹26 cr | 0.0% | — | — | 0.2xQ1 | -9.2%Q1 | -65.6%Q1 | 0.0xQ1 | — | 51.4% | — |
| GALAXY MEDICARE LIMITED | Medical Specialties | ₹26 cr | 0.0% | -9%Q2 | 7.5xQ1 | 0.6xQ1 | 13.9%Q2 | — | 0.1xQ2 | — | 73.0% | 5% |
| WALPAR NUTRITIONS LIMITED | Pharmaceuticals: Other | ₹23 cr | 0.0% | -39%Q1 | 9.3xQ1 | 1.2xQ1 | 14.8%Q3 | — | 0.9xQ4 | — | 68.8% | 10% |
| SUNREST LIFESCIENCE LIMITED | Pharmaceuticals: Generic | ₹15 cr | 0.0% | -0%Q2 | 3.7xQ1 | 0.8xQ1 | 23.2%Q4 | — | 0.8xQ4 | — | 53.5% | 30% |
| ORTIN GLOBAL LIMITED | Pharmaceuticals: Generic | ₹11 cr | 0.0% | +17%Q3 | — | — | — | — | — | -4.7Q1 | 1.2% | 30% |
| JB CHEMICALS & PHARMACEUTICA | Pharmaceuticals: Major | — | — | — | — | — | — | — | — | — | — | 61% |
Sorted by market cap.
Click a column heading to re-sortTap a column heading to re-sort
Dots show a company's quartile within this sector (Q1 = lowest value in the sector, Q4 = highest) for the metrics that have one; hover for the percentile. This is a relative position within this sector only, not a quality score. A hollow dot means loss-making.
Lenders show ROE in place of ROCE and n/a for operating margin and debt/equity. Companies without their own page are listed unlinked. 12m return is the 12-month price change.